A61K38/4886 - page 2 - CPC Classification Index

#301

20160339088

2016-11-24

REDUCTION OF ADIPOSE TISSUE

#302

20160331817

2016-11-17

COMPOSITIONS AND METHODS FOR TREATING FIBROTIC MYOPATHY CONDITIONS USING COLLAGENASE

#303

20160310581

2016-10-27

ADAM10 INHIBITION TO TREAT FRAGILE X SYNDROME

#304

20160287682

2016-10-06

Modulation of muscle and adipocyte distribution and fate

#305

20160279046

2016-09-29

Methods for treating cellulite

#306

20160256530

2016-09-08

Methods and compositions for the identification and treatment of individuals having or likely to develop short stature

#307

20160243245

2016-08-25

Methods and compositions for enhancing intranasal delivery of therapeutic agents

#308

20160208013

2016-07-21

Inhibitors of endoglin activity for the treatment of fibrosis

#309

20160206709

2016-07-21

ANTIMICROBIAL COMPOSITION COMPRISING PYROGENIC SILICA AND SERRATHOPEPTIDASE AND USES THEREOF

#310

20160199425

2016-07-14

Treatment and Prophylaxis for Parkinson's Disease

#311

20160158325

2016-06-09

METHOD OF TREATING FIBROPROLIFERATIVE DISORDERS INCLUDING DUPUYTREN'S DISEASE WITH ONE OR MORE SPECIFIC HUMAN MATRIX METALLOPROTEINASE AND A TNF ANTAGONIST

#312

20160151424

2016-06-02

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#313

20160145590

2016-05-26

Cytolethal distending toxin subunit B conjugated or fused to toxin lethal factor

#314

20160144055

2016-05-26

GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA

#315

20160129050

2016-05-12

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#316

20160129049

2016-05-12

Purified amniotic membrane compositions and methods of use

#317

20160109725

2016-04-21

Contact lens use in the treatment of an ophthalmologic condition

#318

20160089405

2016-03-31

Treatment and prophylaxis for gastroesophageal reflux disease

#319

20160074454

2016-03-17

Pharmaceutical composition based on Centella asiatica (L.) for the treatment of lower limb ulcers

#320

20160053250

2016-02-25

MATRIX METALLOPROTEINASSES AND USES THEREOF

#321

20160051642

2016-02-25

Treatment of Peyronie's disease

#322

20160024206

2016-01-28

Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma

#323

20160015656

2016-01-21

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#324

20160008777

2016-01-14

PHARMACEUTICAL COMPOUNDING KIT

#325

20160008405

2016-01-14

Method of treatment for pulpitis and/or enhancement for dentinogenesis

#326

20160008293

2016-01-14

Dissolvable gel-forming film for delivery of active agents

#327

20160000890

2016-01-07

THERMOSENSITIVE HYDROGEL COLLAGENASE FORMULATIONS

#328

20160000889

2016-01-07

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

#329

20150367115

2015-12-24

Methods and systems for toxin delivery to the nasal cavity

#330

20150359860

2015-12-17

Method of treating fibrosis in skeletal muscle tissue

#331

20150328293

2015-11-19

Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose

#332

20150320845

2015-11-12

System and Method for Modulation of Cardiac Tissue

#333

20150306221

2015-10-29

Mixture of betamethasone and tranilast with a transdermal gel for scar treatment

#334

20150297787

2015-10-22

Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof

#335

20150297687

2015-10-22

PROTEASE COMPOSITIONS FOR THE TREATMENT OF DAMAGED TISSUE

#336

20150297686

2015-10-22

TISSUE REGENERATION PROMOTING AGENT

#337

20150284701

2015-10-08

Fusion proteins of collagen-binding domain and parathyroid hormone

#338

20150284688

2015-10-08

Diffusible factors and cancer cells

#339

20150283217

2015-10-08

Stable thermolysin hydrogel

#340

20150273028

2015-10-01

Use of collagenase to treat glaucoma

#341

20150266935

2015-09-24

Peptide directed protein knockdown

#342

20150247138

2015-09-03

Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

#343

20150238577

2015-08-27

Chimeric polypeptides and their use in bacterial decolonization

#344

20150218644

2015-08-06

Therapy with enterotoxin to treat ovarian and uterine cancer

#345

20150218288

2015-08-06

Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor

#346

20150216952

2015-08-06

Treatment of ophthalmic conditions

#347

20150196625

2015-07-16

Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof

#348

20150182607

2015-07-02

Use of proteases for gluten intolerance

#349

20150182606

2015-07-02

Multimodal antimicrobial therapy

#350

20150182605

2015-07-02

Ultra-Low Dose Lysostaphin for Treating MRSA

#351

20150174216

2015-06-25

Methods for Treating Adhesive Capsulitis

#352

20150174208

2015-06-25

Cosmetic and pharmaceutical composition with modified olygopeptides in form of supramolecular assembly

#353

20150165002

2015-06-18

Exfoliative hair retention-promoting formulation

#354

20150147313

2015-05-28

Animal product-free culture medium and a process for producing a supernatant of clostridium comprising one or more collagenolytic and gelatinolytic proteases

#355

20150132281

2015-05-14

Variants of TACE pro-domain as TNF-A inhibitor and their medical use

#356

20150118212

2015-04-30

Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation

#357

20150104439

2015-04-16

Pharmaceutical removal of neuronal extensions from a degenerating disc

#358

20150093373

2015-04-02

Treatment of pulmonary vascular remodeling with neprilysin

#359

20150093372

2015-04-02

Gelatinase inhibitors and prodrugs

#360

20150079194

2015-03-19

Systems, compositions, and methods for transplantation and treating conditions

#361

20150079069

2015-03-19

METHODS FOR MODIFICATION OF TISSUES

#362

20150064165

2015-03-05

Devices and methods for reducing the appearance of cellulite

#363

20150064163

2015-03-05

BMP Peptides & Methods of Use

#364

20150056179

2015-02-26

Process for the production and purification of the collagenase enzyme from vibrio alginolyticus

#365

20150050716

2015-02-19

ADAMTS-13 mutant

#366

20150050617

2015-02-19

Methods for extracting a tooth

#367

20150044171

2015-02-12

Gain-of-function ADAMTS13 variants resistant to auto antibody inhibition and methods of use thereof

#368

20150030583

2015-01-29

Methods of Treating Serosal Cancer

#369

20150017151

2015-01-15

Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

#370

20150010575

2015-01-08

Combination therapy for the treatment of cancer using an anti-C-met antibody

#371

20150010532

2015-01-08

Clostridium histolyticum enzymes and methods for the use thereof

#372

20150005367

2015-01-01

ADAM12 inhibitors and their use against inflammation-induced fibrosis

#373

20140377319

2014-12-25

ALTERING PROTEIN CONCENTRATIONS IN CEREBROSPINAL FLUID AND/OR BRAIN INTERSTITIAL FLUID

#374

20140377249

2014-12-25

Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers

#375

20140369987

2014-12-18

DERMASEPTIN B2 USED AS AN INHIBITOR OF THE GROWTH OF A TUMOR

#376

20140341882

2014-11-20

PHARMACEUTICAL PRODUCT FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE

#377

20140341801

2014-11-20

INACTIVATION OF SMOOTH MUSCLE TISSUE

#378

20140335146

2014-11-13

Growth factor anchoring type bone graft material, method for producing growth factor anchoring type bone graft material, kit for producing growth factor anchoring type bone graft material, and method for forming bone

#379

20140335072

2014-11-13

Method of Treating or Reducing EFP

#380

20140328892

2014-11-06

USE OF ALFIMEPRASE IN THE TREATMENT OF THROMBOSIS

#381

20140322190

2014-10-30

Pharmaceutical compositions and methods for digesting atherosclerotic plaques

#382

20140302142

2014-10-09

Compositions and methods for enhancing penetration of biologically active substances into tissues or organs

#383

20140302122

2014-10-09

Fungal-specific metalloproteases and uses thereof

#384

20140290666

2014-10-02

Treatment of carpal tunnel syndrome by injection of the flexor retinaculum

#385

20140287032

2014-09-25

Treatment method and product for uterine fibroids using purified collagenase

#386

20140286962

2014-09-25

REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS

#387

20140286929

2014-09-25

Proteomic IPF markers

#388

20140271612

2014-09-18

Treatment method and product for uterine fibroids using purified collagenase

#389

20140271611

2014-09-18

Subcutaneous administration of ADAMTS13

#390

20140271597

2014-09-18

Treatment of ophthalmic conditions

#391

20140248258

2014-09-04

METHODS FOR IMPROVING GUT HEALTH

#392

20140219992

2014-08-07

Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof

#393

20140219969

2014-08-07

Cell therapy for the treatment of neurodegeneration

#394

20140212405

2014-07-31

Fibrinolytic/Proteolytic Treatment of Myofacial and Neuropathic Pain and Related Conditions

#395

20140205643

2014-07-24

Use of alginate oligomers in combating biofilms

#396

20140199289

2014-07-17

Use of matrix metalloproteinase inhibitors to treat tuberculosis

#397

20140193394

2014-07-10

Treatment of carpal tunnel syndrome by injection of the flexor retinaculum

#398

20140178357

2014-06-26

Stabilized liquid and lyophilized ADAMTS13 formulations

#399

20140142718

2014-05-22

Flexible tissue matrix and methods for joint repair

#400

20140050718

2014-02-20

Methods and compositions for enhancing intranasal delivery of therapeutic agents

#401

20140044698

2014-02-13

Method of peptide hydrolysis, peptidase, the composition for use as a bacteriostatic and bactericidal agent, a kit and the uses of the active form of LytM from or derivatives thereof

#402

20140017225

2014-01-16

Metalloproteinase-9 oligopeptides and their therapeutic use

#403

20140017220

2014-01-16

Treatment of ophthalmic conditions

#404

20140004098

2014-01-02

Methods of treatment with elastase

#405

20140004094

2014-01-02

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

#406

20130330320

2013-12-12

Methods for Treating Adhesive Capsulitis

#407

20130316455

2013-11-28

Method of isolating cells from a tissue in a mammal

#408

20130302296

2013-11-14

Treatment and prophylaxis for obsessive compulsive disorder

#409

20130287817

2013-10-31

Flowable implant with crosslinkable surface membrane

#410

20130287759

2013-10-31

Collagenase G and Collagenase H compositions for the treatment of diseases involving alterations of collagen

#411

20130280344

2013-10-24

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#412

20130280223

2013-10-24

Functionalized tissue matrices

#413

20130251699

2013-09-26

Methods of degrading or inhibiting botulinum neurotoxin using designer ubiquitin ligases

#414

20130236439

2013-09-12

Enzyme-activated collagen and tissue matrices

#415

20130195994

2013-08-01

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#416

20130195993

2013-08-01

Purified amniotic membrane compositions and methods of use

#417

20130195838

2013-08-01

Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases

#418

20130195828

2013-08-01

Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques

#419

20130177528

2013-07-11

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL INFECTION

#420

20130171156

2013-07-04

Methods of preventing ischemia/reperfusion damage to kidney using antibodies that bind BMP-1 isoforms

#421

20130171127

2013-07-04

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#422

20130171122

2013-07-04

ENDOPEPTIDASE AND NEUROTOXIN COMBINATION TREATMENT OF BLADDER DISORDERS

#423

20130156884

2013-06-20

PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME

#424

20130156726

2013-06-20

ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME

#425

20130136732

2013-05-30

ADAMTS13-containing compositions having thrombolytic activity

#426

20130129697

2013-05-23

Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

#427

20130108614

2013-05-02

Wound healing peptides and methods of use thereof

#428

20130084320

2013-04-04

TISSUE FUSION METHOD USING COLLAGENASE FOR REPAIR OF SOFT TISSUE

#429

20130052184

2013-02-28

Gelatinase inhibitors and prodrugs

#430

20130045196

2013-02-21

Enzymatic wound debriding compositions with enhanced enzymatic activity

#431

20130045192

2013-02-21

REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS

#432

20130045191

2013-02-21

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#433

20130034531

2013-02-07

Use of proteases for gluten intolerance

#434

20130012451

2013-01-10

COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION

#435

20130011423

2013-01-10

METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE

#436

20130004476

2013-01-03

Chimeric polypeptides and their use in bacterial decolonization

#437

20120328690

2012-12-27

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#438

20120309689

2012-12-06

Hatching fluid enzymes and uses thereof

#439

20120308541

2012-12-06

PHARMACEUTICAL COMPOSITION FOR TREATING THE GASTROINTESTINAL TRACT

#440

20120282242

2012-11-08

COMPOSITIONS, TARGETS, METHODS AND DEVICES FOR THE THERAPY OF OCULAR AND PERIOCULAR DISORDERS

#441

20120269880

2012-10-25

Purified amniotic membrane compositions and methods of use

#442

20120252031

2012-10-04

Compositions and methods for regulating SAS1R

#443

20120251523

2012-10-04

Methods of modulating TGFβ signaling

#444

20120238592

2012-09-20

Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine

#445

20120237497

2012-09-20

Compositions and methods for producing clostridial collagenases

#446

20120230975

2012-09-13

Fusion proteins

#447

20120225094

2012-09-06

Treatment of Sleep Disordered Breathing with Neurotoxin

#448

20120225082

2012-09-06

ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis

#449

20120225050

2012-09-06

Methods for improving gut health

#450

20120225049

2012-09-06

Fast acting SNARE-cleaving enzymes

#451

20120220925

2012-08-30

Reduced-pressure treatment systems and methods employing debridement mechanisms

#452

20120220924

2012-08-30

Reduced-pressure treatment systems and methods employing debridement mechanisms

#453

20120207848

2012-08-16

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#454

20120195952

2012-08-02

Implantable matrix having optimum ligand concentrations

#455

20120195945

2012-08-02

Cosmetic and pharmaceutical compositions having modified proteins in the form of a supramolecular assembly

#456

20120189610

2012-07-26

Treatment of pain

#457

20120184498

2012-07-19

DERMASEPTIN B2 USED AS AN INHIBITOR OF THE GROWTH OF A TUMOR

#458

20120156186

2012-06-21

Non-cytotoxic protein conjugates

#459

20120156178

2012-06-21

Treatment of Peyronies disease

#460

20120141511

2012-06-07

CLOSTRIDIAL TOXIN DERIVATIVES ABLE TO MODIFY PERIPHERAL SENSORY AFFERENT FUNCTIONS

#461

20120121573

2012-05-17

Treatment of pulmonary vascular remodeling with neprilysin

#462

20120101027

2012-04-26

Inhibition of secretion from non-neuronal cells

#463

20120100125

2012-04-26

LOCAL DEHYDRATION FOR CARPAL TUNNEL SYNDROME

#464

20120089078

2012-04-12

Methods and systems for toxin delivery to the nasal cavity

#465

20120071421

2012-03-22

Therapy with enterotoxin to treat ovarian and uterine cancer

#466

20120070423

2012-03-22

ORAL COMPOSITION AND METHOD OF FORMING AND USING SAME

#467

20120064057

2012-03-15

ADAMTS-13 mutant

#468

20120052110

2012-03-01

METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING

#469

20120021969

2012-01-26

PROSTHETIC IMPLANT SHELL

#470

20120004627

2012-01-05

Apparatus and methods for enzymatic debridement of skin lesions

#471

20120003205

2012-01-05

Pharmaceutical composition containing arazyme for the prevention of liver dysfunction

#472

20120003204

2012-01-05

Composition containing arazyme for the prevention and treatment of cancer

#473

20110311509

2011-12-22

Treatment of ocular diseases

#474

20110305750

2011-12-15

Membrane type-1 matrix metalloprotein inhibitors and uses thereof

#475

20110301228

2011-12-08

GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA

#476

20110300161

2011-12-08

Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma

#477

20110293559

2011-12-01

CATABOLIC AGENTS

#478

20110286937

2011-11-24

SYNTHETIC GLYCOLIPID-CONTAINING LIPOSOME

#479

20110280909

2011-11-17

METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE

#480

20110243920

2011-10-06

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

#481

20110243919

2011-10-06

Compositions and Methods for Treating Collagen-Mediated Diseases

#482

20110243909

2011-10-06

Compositions and Methods for Treating Collagen-Mediated Diseases

#483

20110243908

2011-10-06

Compositions and Methods for Treating Collagen-Mediated Diseases

#484

20110229504

2011-09-22

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#485

20110229455

2011-09-22

Stabilized liquid and lyophilized ADAMTS13 formulations

#486

20110229451

2011-09-22

TEMPERATURE SENSITIVE MUTANTS OF MATRIX METALLOPROTEASES AND USES THEREOF

#487

20110200981

2011-08-18

Polymerized Hemoglobin Media And Its Use In Isolation And Transplantation of Islet Cells

#488

20110200574

2011-08-18

USE OF PROTEASES FOR GLUTEN INTOLERANCE

#489

20110189163

2011-08-04

Compositions and Methods for Treating Collagen-Mediated Diseases

#490

20110189153

2011-08-04

Compositions and Methods for Treating Collagen-Mediated Diseases

#491

20110184330

2011-07-28

Inactivation of smooth muscle tissue

#492

20110182876

2011-07-28

Methods of prolonging patency of hemodialysis access

#493

20110182874

2011-07-28

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#494

20110182873

2011-07-28

Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#495

20110177050

2011-07-21

Methods comprising serratia peptidase for inhibition of osteomyelitis

#496

20110177049

2011-07-21

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#497

20110177048

2011-07-21

Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis

#498

20110171202

2011-07-14

METHOD OF TREATING HEARING LOSS USING XIAP

#499

20110171189

2011-07-14

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

#500

20110158972

2011-06-30

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

#501

20110152174

2011-06-23

INHIBITION OF SECRETION FROM NON-NEURONAL CELLS

#502

20110150765

2011-06-23

Frozen compositions and methods for piercing a substrate

#503

20110142808

2011-06-16

Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells

#504

20110135703

2011-06-09

Antimicrobial Coating for Surgical Implants and Method of Use

#505

20110135576

2011-06-09

Dye conjugates of template-fixed peptidomimetics

#506

20110130783

2011-06-02

Treatment of obesity and related disorders

#507

20110129454

2011-06-02

Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

#508

20110110922

2011-05-12

Wound healing peptides and methods of use thereof

#509

20110097379

2011-04-28

Renal tissue regeneration

#510

20110091437

2011-04-21

FUSION PROTEINS

#511

20110091436

2011-04-21

Use of matrix metalloproteinase-10 (MMP-10) for thrombolytic treatments

#512

20110091421

2011-04-21

Methods of novel therapeutic candidate identification through gene expression analysis in vascular-related diseases

#513

20110081320

2011-04-07

Treatment/Cure of Autoimmune Disease

#514

20110076281

2011-03-31

BMP-1 PROCOLLAGEN C-PROTEINASE FOR DIAGNOSIS AND TREATMENT OF BONE AND SOFT TISSUE DEFECTS AND DISORDERS

#515

20110070621

2011-03-24

Multivalent clostridial toxins

#516

20110070186

2011-03-24

Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases

#517

20110054442

2011-03-03

Cell membrane translocation of regulated snare inhibitors, compositions therefor, and methods for treatment of disease

#518

20110044968

2011-02-24

COMPOSITIONS FOR TREATMENT WITH METALLOPEPTIDASES, METHODS OF MAKING AND USING THE SAME

#519

20110044960

2011-02-24

MEDICAMENT, DENTAL MATERIAL, AND METHOD OF SCREENING

#520

20110033463

2011-02-10

APHERESIS, ADMINISTRATION OF AGENT, OR COMBINATION THEREOF

#521

20110027251

2011-02-03

NOVEL USES FOR 4-PHENYLBUTYRATE (4PBA) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

#522

20110021422

2011-01-27

Method and compositions for prevention and treatment of diabetic and aged skin

#523

20110002914

2011-01-06

HYBRID TETNUS TOXOID PROTEINS THAT MIGRATE RETROGRADELY AND TRANSYNAPTICALLY INTO THE CNS

#524

20110002883

2011-01-06

THERAPEUTIC PREPARATIONS CONTAINING WHARTON'S JELLY

#525

20100330065

2010-12-30

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

#526

20100322917

2010-12-23

PHARMACEUTICAL COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION OF LIVER DYSFUNCTION

#527

20100305062

2010-12-02

Use of alginate oligomers in combating biofilms

#528

20100291062

2010-11-18

Antimicrobial composition comprising pyrogenic silica and serratiopeptidase

#529

20100284995

2010-11-11

Temperature sensitive mutants of matrix metalloproteases and uses thereof

#530

20100278806

2010-11-04

Composition Containing Arazyme for the Prevention and Treatment of Arthritis

#531

20100262118

2010-10-14

Methods for identifying areas of a subject's skin that appear to lack volume

#532

20100261656

2010-10-14

Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin

#533

20100247513

2010-09-30

Treatment of carpal tunnel syndrome by injection of the flexor retinaculum

#534

20100247512

2010-09-30

Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue

#535

20100239534

2010-09-23

Hybrid proteins that migrate retrogradely and transynaptically into the CNS

#536

20100233151

2010-09-16

COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES

#537

20100233150

2010-09-16

REDUCTION OF ADIPOSE TISSUE

#538

20100233111

2010-09-16

GASTROPOD BIOLOGICAL FLUID, METHOD OF MAKING AND REFINING AND USE

#539

20100221236

2010-09-02

Mutants of Staphylokinase Carrying Amino and Carboxy-Terminal Extensions for Polyethylene Glycol Conjugation

#540

20100203034

2010-08-12

Methods for the treatment and prevention of diseases of biological conduits

#541

20100187728

2010-07-29

Systems, devices, and methods for making or administering frozen particles

#542

20100185174

2010-07-22

Systems, devices, and methods for making or administering frozen particles

#543

20100183617

2010-07-22

COMPOSITIONS AND METHODS FOR REGULATING SAS1R

#544

20100168900

2010-07-01

Systems, devices, and methods for making or administering frozen particles

#545

20100163576

2010-07-01

Systems, devices, and methods for making or administering frozen particles

#546

20100160871

2010-06-24

Reduced-pressure treatment systems and methods employing debridement mechanisms

#547

20100160849

2010-06-24

Methods for identifying areas of a subject's skin that appear to lack volume

#548

20100152880

2010-06-17

Systems, devices and methods for making or administering frozen particles

#549

20100152651

2010-06-17

Frozen compositions and methods for piercing a substrate

#550

20100143243

2010-06-10

Frozen compositions and methods for piercing a substrate

#551

20100129341

2010-05-27

Fusion proteins of collagen-binding domain and parathyroid hormone

#552

20100121466

2010-05-13

Frozen compositions and methods for piercing a substrate

#553

20100119557

2010-05-13

Frozen compositions and array devices thereof

#554

20100114348

2010-05-06

Frozen compositions and methods for piercing a substrate

#555

20100111855

2010-05-06

Frozen piercing implements and methods for piercing a substrate

#556

20100111854

2010-05-06

Frozen compositions and methods for piercing a substrate

#557

20100087775

2010-04-08

Methods and systems for toxin delivery to the nasal cavity

#558

20100061972

2010-03-11

Method of Treating Peyronie's Disease

#559

20100040596

2010-02-18

USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC TREATMENTS

#560

20100034802

2010-02-11

TREATMENT OF PAIN

#561

20100029665

2010-02-04

Methods and Compositions for Treating Migraine Pain

#562

20100021450

2010-01-28

Lys K endolysin is synergistic with lysostaphin against MRSA

#563

20100021416

2010-01-28

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

#564

20100015116

2010-01-21

Designer ubiquitin ligases having a non-cleavable SNAP25 domain and E3-ligase domain

#565

20090317375

2009-12-24

VON WILLEBRAND FACTOR (VWF) INHIBITORS FOR TREATMENT OR PREVENTION OF INFARCTION

#566

20090317374

2009-12-24

COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANCER

#567

20090317364

2009-12-24

NOVEL COMPOSITIONS FOR PREVENTION AND TREATMENT OF MASTITIS AND METRITIS

#568

20090311236

2009-12-17

Therapeutic Peptide Compositions And Methods Of Making And Using Same

#569

20090304673

2009-12-10

Method of Treatment of Inflammatory Diseases

#570

20090291047

2009-11-26

Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer

#571

20090280066

2009-11-12

Methods and compounds for the treatment of mucus hypersecretion

#572

20090269405

2009-10-29

ENZYME MEDIATED DELIVERY SYSTEM

#573

20090226468

2009-09-10

Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS

#574

20090220463

2009-09-03

Pharmaceutical Composition For Treating Vascular-Related Diseases Comprising Peptide

#575

20090203110

2009-08-13

Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV

#576

20090202517

2009-08-13

AGENTS FOR IMPROVING INFLAMMATORY BOWEL DISEASE

#577

20090191255

2009-07-30

BMP-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders

#578

20090186052

2009-07-23

USE OF BOTULINUM TOXIN FOR PORLONGED LOCAL DESENSITIZATION

#579

20090175842

2009-07-09

DIETARY ANTI-BACTERIAL COMPOSITIONS

#580

20090163311

2009-06-25

Series spring blade tensioner

#581

20090155278

2009-06-18

Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer

#582

20090131645

2009-05-21

Clostridial toxin derivatives able to modify peripheral sensory afferent functions

#583

20090130185

2009-05-21

Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase

#584

20090123454

2009-05-14

Methods for treating adhesive capsulitis

#585

20090104234

2009-04-23

METHODS OF TREATING CHRONIC NEUROGENIC INFLAMMATION USING MODIFIED CLOSTRIDIAL TOXINS

#586

20090075937

2009-03-19

LHRH ANTAGONISTS FOR THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS

#587

20090074744

2009-03-19

Use of collagenase to facilitate guide wire crossing in total arterial occlusions

#588

20090068251

2009-03-12

Methods and compositions for promoting wound healing

#589

20090060953

2009-03-05

Methods for using tetanus toxin for beneficial purposes in animals (mammals)

#590

20090060897

2009-03-05

System comprising elastase

#591

20090060893

2009-03-05

Methods for enlarging the lumen of an obstructed biological conduit

#592

20090053182

2009-02-26

ENDOMETRIAL STEM CELLS AND METHODS OF MAKING AND USING SAME

#593

20090048431

2009-02-19

Multivalent clostridial toxins

#594

20090017467

2009-01-15

Composition exhibiting a von Willebrand Factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV

#595

20090010918

2009-01-08

Method for treating lateral epicondylitis using collagenase

#596

20090010869

2009-01-08

Compositions for Topical Enzymatic Debridement

#597

20080319167

2008-12-25

Clostridial toxin derivatives able to modify peripheral sensory afferent functions

#598

20080317736

2008-12-25

Methods for enlarging the diameter of a biological conduit in a human subject

#599

20080311103

2008-12-18

Anti-Inflammatory Peptides and Methods of Use Thereof

#600

20080299087

2008-12-04

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition